Inhibition of yeast ribonucleotide reductase by Sml1 depends on the allosteric state of the enzyme

FEBS Lett. 2016 Jun;590(12):1704-12. doi: 10.1002/1873-3468.12207. Epub 2016 May 27.

Abstract

Sml1 is an intrinsically disordered protein inhibitor of Saccharomyces cerevisiae ribonucleotide reductase (ScRR1), but its inhibition mechanism is poorly understood. RR reduces ribonucleoside diphosphates to their deoxy forms, and balances the nucleotide pool. Multiple turnover kinetics show that Sml1 inhibition of dGTP/ADP- and ATP/CDP-bound ScRR follows a mixed inhibition mechanism. However, Sml1 cooperatively binds to the ES complex in the dGTP/ADP form, whereas with ATP/CDP, Sml1 binds weakly and noncooperatively. Gel filtration and mutagenesis studies indicate that Sml1 does not alter the oligomerization equilibrium and the CXXC motif is not involved in the inhibition. The data suggest that Sml1 is an allosteric inhibitor.

Keywords: enzyme kinetics; intrinsically disordered protein; mixed inhibition; nucleotides; oligomerization.

Publication types

  • Letter

MeSH terms

  • Allosteric Regulation / physiology
  • Amino Acid Motifs
  • Protein Binding / physiology
  • Protein Multimerization / physiology
  • Ribonucleotide Reductases / chemistry*
  • Ribonucleotide Reductases / genetics
  • Ribonucleotide Reductases / metabolism
  • Saccharomyces cerevisiae / chemistry*
  • Saccharomyces cerevisiae / genetics
  • Saccharomyces cerevisiae / metabolism
  • Saccharomyces cerevisiae Proteins / chemistry*
  • Saccharomyces cerevisiae Proteins / genetics
  • Saccharomyces cerevisiae Proteins / metabolism

Substances

  • SML1 protein, S cerevisiae
  • Saccharomyces cerevisiae Proteins
  • Ribonucleotide Reductases
  • Rnr1 protein, S cerevisiae